Diflucortolone
Chemical compound
- D07AC06 (WHO)
D07XC04 (WHO) (combinations)
- 2607-06-9
- 11954369
- DB09095
Y
- 10128664
- K253365DXI
- D03812 Y
- DTXSID50180705
- Interactive image
- C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C)F
InChI
- InChI=1S/C22H28F2O4/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-21(15,3)22(14,24)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1
- Key:OGPWIDANBSLJPC-RFPWEZLHSA-N
Diflucortolone (INN), or difluocortolone, is a corticosteroid.[1]
See also
- Diflucortolone valerate
References
- ^ Soto JM, Villalba Pimentel L, Alvarado Romero J (1977). "[Clinical comparative study of between difluocortolone and flumethasone]". Medicina Cutanea Ibero-Latino-Americana. 5 (4): 267–270. PMID 364210.
- v
- t
- e
Glucocorticoids and antiglucocorticoids (D07, H02)
| Natural | |
|---|---|
| Synthetic |
|
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
